STAT3 regulatedmiR-216apromotes ovarian cancer proliferation and cisplatin resistance
出版年份 2018 全文链接
标题
STAT3 regulatedmiR-216apromotes ovarian cancer proliferation and cisplatin resistance
作者
关键词
-
出版物
BIOSCIENCE REPORTS
Volume 38, Issue 4, Pages BSR20180547
出版商
Portland Press Ltd.
发表日期
2018-07-31
DOI
10.1042/bsr20180547
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers
- (2018) Yu Han et al. JOURNAL OF CONTROLLED RELEASE
- miR-455 inhibits breast cancer cell proliferation through targeting CDK14
- (2017) Bing Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
- (2017) Chiranjib Chakraborty et al. Molecular Therapy-Nucleic Acids
- miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells
- (2016) Jing Song et al. CANCER SCIENCE
- Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target
- (2016) U Saini et al. ONCOGENE
- Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway
- (2015) Wei Xu et al. CANCER LETTERS
- miR-216a may inhibit pancreatic tumor growth by targeting JAK2
- (2015) Bao-hua Hou et al. FEBS LETTERS
- Inhibition of cisplatin-resistance by RNA interference targeting metallothionein using reducible oligo-peptoplex
- (2015) Jong-Hwan Lee et al. JOURNAL OF CONTROLLED RELEASE
- Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line
- (2015) Jian-Huang Li et al. TUMOR BIOLOGY
- Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer
- (2015) Yan Gao et al. Oncotarget
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- MicroRNA Processing and Human Cancer
- (2015) Masahisa Ohtsuka et al. Journal of Clinical Medicine
- MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
- (2014) Nicolai A. Schultz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
- (2014) Christopher J. Cheng et al. NATURE
- MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2
- (2014) SILIANG WANG et al. ONCOLOGY REPORTS
- A Ten-MicroRNA Signature Identified from a Genome-Wide MicroRNA Expression Profiling in Human Epithelial Ovarian Cancer
- (2014) Lin Wang et al. PLoS One
- Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly
- (2013) X. Zhang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- (2013) Hongping Xia et al. HEPATOLOGY
- Abstract 4412: Prognostic significance of NF-κB in Middle Eastern diffuse large B cell lymphoma and efficacy of NF-κB inhibition as a viable therapeutic target
- (2012) Prashant Bavi et al. CANCER RESEARCH
- Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
- (2012) D. J. Mulholland et al. CANCER RESEARCH
- miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma
- (2011) Min Deng et al. JOURNAL OF CELL SCIENCE
- Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
- (2011) Barbara Norquist et al. JOURNAL OF CLINICAL ONCOLOGY
- STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer
- (2010) Dimitrios Iliopoulos et al. MOLECULAR CELL
- Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
- (2010) Yunching Chen et al. MOLECULAR THERAPY
- Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
- (2010) S L Cooke et al. ONCOGENE
- Plasma miR-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitis
- (2010) Xiang-Yu Kong WORLD JOURNAL OF GASTROENTEROLOGY
- BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer Cells
- (2009) M. Mani et al. CANCER RESEARCH
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
- (2009) Janaiah Kota et al. CELL
- Krüppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression
- (2009) Yu Nakamura et al. INTERNATIONAL JOURNAL OF CANCER
- Maintenance Therapy for Ovarian Cancer: Of Helsinki and Hippocrates
- (2009) William Patrick McGuire JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer
- (2008) Neetu Dahiya et al. PLoS One
- Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
- (2008) L. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started